+97.3%
GSK vs EME
+838.7%
-741.4%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | EME | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.6% | -1.6% | 0.0% | -1.4% |
| 7D | -4.7% | -4.0% | -0.7% | -4.4% |
| 30D | -4.7% | -9.5% | +4.8% | -4.1% |
| 3M | -8.8% | -21.0% | +12.3% | -7.1% |
| 6M | -4.6% | -25.5% | +20.8% | -2.7% |
| YTD | +1.0% | +4.2% | -3.2% | -1.1% |
| 1Y | +6.9% | +5.2% | +1.7% | +4.5% |
| 3Y | +52.5% | +198.3% | -145.8% | +22.0% |
| 5Y | +40.3% | +399.1% | -358.8% | +0.3% |
| All | +97.3% | +838.7% | -741.4% | +23.6% |
Cumulative growth
Daily Returns
Daily percentage return beside EME.
Daily Out/Under-Performance
Portfolio return minus EME return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EME return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded EME wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling